Stock Taper 
TCG CROSSOVER MANAGEMENT, LLC
Latest 13F filing data - Q2 2026
Holdings
(Top positions)| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
 Editas Medicine, Inc. | EDIT | 11.11M | $36M |
 BioCryst Pharmaceuticals, Inc. | BCRX | 11.02M | $110.21M |
 Altimmune, Inc. | ALT | 10M | $30.4M |
 Aura Biosciences, Inc. | AURA | 9.53M | $67.69M |
 Tango Therapeutics, Inc. | TNGX | 9.08M | $283.88M |
 Amylyx Pharmaceuticals, Inc. | AMLX | 6.24M | $112.14M |
 Abivax S.A. | ABVX | 6.01M | $800.6M |
 Cogent Biosciences, Inc. | COGT | 4.85M | $187.87M |
 Monte Rosa Therapeutics, Inc. | GLUE | 4.62M | $111.86M |
 Dyne Therapeutics, Inc. | DYN | 4.62M | $102.5M |
 Immunovant, Inc. | IMVT | 4.46M | $171.77M |
 Relay Therapeutics, Inc. | RLAY | 4.27M | $79.95M |
 CG Oncology Inc. | CGON | 3.67M | $260.77M |
 Tyra Biosciences, Inc. | TYRA | 3.25M | $103.77M |
 First Tracks Biotherapeutics Inc | TRAX | 2.9M | $58.25M |
 Xencor, Inc. | XNCR | 2.45M | $39.48M |
 Spyre Therapeutics, Inc. | SYRE | 1.9M | $168.73M |
 Janux Therapeutics, Inc. | JANX | 1.79M | $27.49M |
 Biohaven Ltd. | BHVN | 1.78M | $26.49M |
 Dianthus Therapeutics, Inc. | DNTH | 1.68M | $163.44M |